A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Methylation-specific PCR method for MGMT coding gene silencing evaluation and its prognostic significance in alkylating antitumor treatment
unpublished
Preserved Fulltext
MGMT (O6-methyl-guanine-DNA methyltransferase) is a protein with a specific enzyme activity that is involved in repair of DNA alkylation alterations introduced by classical chemotherapy, such as involving temozolomide (TMZ) use for glioma and Ewing sarcoma tumors. The MGMT methylation biomarker is frequently used for the evaluation of the treatment prognosis in such type of classical anticancer approach. In this article, optimized analytical conditions of a nested MS-PCR method for the
fatcat:myxdpj2o3zetdkybkf64xmh3nu